Abstract：Objective: To analyze the expressions of micro RNA-181a (miR-181a) and caudal type homologous transcription factor-2 (CDX2) in gastric mucosa, and to explore their relationships with clinicopathological parameters and prognosis in patients with chronic atrophic gastritis (CAG). Methods: 90 patients with CAG admitted from February 2017 to September 2018 were selected as the study subjects, atrophic mucosal biopsy tissues and surrounding normal mucosal biopsy tissues were retained during gastroscopy. Real-time fluorescence quantitative PCR (qRT-PCR) was used to detect the expression of miR-181a in biopsy tissues, immunohistochemical staining (SP method) was used to detect the expression of CDX2 protein; analyzed their expressions in different tissues and their relationships with clinicopathological parameters and prognosis of CAG patients. Results: The expression level of miR-181a in CAG gastric mucosa was significantly higher than that in normal gastric mucosa (P<0.05), and the positive rate of CDX2 protein was significantly higher than that in normal gastric mucosa (P<0.05). The expressions of miR-181a and CDX2 were not related to sex, Hp infection and chronic inflammation (P>0.05), but to atrophy of gastric mucosa, intestinal metaplasia and atypical hyperplasia in CAG patients (P<0.05). The expressions of miR-181a and CDX2 were related to the prognosis of CAG patients (P<0.05). Conclusion: MiR-181a and CDX2 are highly expressed in gastric mucosa of CAG, their expressions are related to the clinicopathological parameters such as atrophy of gastric mucosa and intestinal metaplasia, and prognosis of CAG patients, which can provide some help for clinical treatment.
许辰, 高泽立, 张建表, 杭冬云, 王晴玉. 慢性萎缩性胃炎患者miR-181a和CDX2表达变化及与预后关系[J]. 河北医学, 2019, 25(11): 1782-1786.
XU Chen, GAO Zeli, ZHANG Jianbiao, et al. Changes of Expression of MiR-181a and CDX2 in Patients with Chronic Atrophic Gastritis and the Relationship with Prognosis. HeBei Med, 2019, 25(11): 1782-1786.
[1] 徐亚熙,胡海青,魏夫荣,等.应用定标活检评价根除幽门螺杆菌联合替普瑞酮和叶酸治疗萎缩性胃炎病理组织学的疗效[J].医学研究杂志,2016,45(1):109~112. [2] Saito M, Okayama H, Saito K, et al. CDX2 is involved in microRNA-associated inflammatory carcinogenesis in gastric cancer[J]. Oncol Lett, 2017, 14(5):6184~6190. [3] Shi Q, Zhou Z, Ye N, et al. MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1[J]. Cancer Biomark, 2017, 20(4):539~546. [4] Dalerba P, Sahoo D, Paik S, et al. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer[J]. N Engl Med, 2016, 374(3):211~222. [5] 李军祥,陈誩,吕宾,等.慢性萎缩性胃炎中西医结合诊疗共识意见(2017年)[J].中国中西医结合消化杂志,2018,26(2):121~131. [6] Liao Y, Shen L, Zhao H, et al. LncRNA CASC2 interacts with miR-181a to modulate glioma growth and resistance to TMZ through PTEN pathway[J].Cell Biochem, 2017, 118(7):1889~1899. [7] 郑锡铭,娄峻.RA患者外周血及关节液中miR-132、miR-140-5p、miR-150及miR-181a表达水平的临床意义[J].热带医学杂志,2018,18(3):362~366. [8] 李美灵,曾淑梅,纪晓丹,等.Ⅰ型和Ⅱ型子宫内膜癌中miR-181a与CA-125的表达及相关性研究[J].解放军医学杂志,2016,41(1):26~30. [9] Zhang BY, Jones JC, Briggler AM, et al. Lack of caudal-type homeobox transcription factor 2 expression as a prognostic biomarker in metastatic colorectal cancer[J]. Clin Colorectal Cancer, 2017, 16(2):124~128. [10] Zheng J, He S, Qi J, et al. Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo[J]. Int J Oncol, 2017, 51(2):478~488. [11] 许良璧,项一宁,杨浩羿,等.糜烂性食管炎、Barrett食管及食管腺癌中SOX2、CDX2的表达及其临床意义[J].临床与实验病理学杂志,2016,32(9):1014~1018. [12] 孙丹,武洋,辛彦.SoX2和CDX2基因编码蛋白在胃癌及其癌前病变中的表达及意义[J].现代肿瘤医学,2016,24(10):1585~1591. [13] Jiang Y, Zhang Y, Li F, et al. CDX2 inhibits pancreatic adenocarcinoma cell proliferation via promoting tumor suppressor miR-615-5p[J]. Tumour Biol, 2016, 37(1):1041~1049.
2019, Vol. 25 
冀公网安备13080202000677号